Pacific Programme to Eliminate Lymphatic Filariasis
In 1999, WHO launched the Pacific Programme to Eliminate Lymphatic Filariasis (PacELF) as the Pacific arm of the Global Programme, which aims to eliminate lymphatic filariasis (LF) as a Public Health problem by 2020. The two strategies to achieve this goal are:
- to interupt transmission of filarial infection through either yearly rounds of mass drug administration (MDA) using a combination of 2 drugs (Albendazole and Diethylcarbamazine, in the Pacific) for at least 5 years or through community use of DEC-salt; and
- to control the LF morbidity to alleviate and prevent the suffering and disability of affected individuals.
The Pacific Programme is coordinated by WHO professional staff based in the Office of the WHO Representative for the South Pacific (WHO/SP) in Suva, FIJI. Material, equipment and part of the administration of the program is located at Mataika House, the Fiji Center for Communicable Diseases Control.